GB201612095D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB201612095D0
GB201612095D0 GBGB1612095.8A GB201612095A GB201612095D0 GB 201612095 D0 GB201612095 D0 GB 201612095D0 GB 201612095 A GB201612095 A GB 201612095A GB 201612095 D0 GB201612095 D0 GB 201612095D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1612095.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almac Discovery Ltd
Original Assignee
Almac Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almac Discovery Ltd filed Critical Almac Discovery Ltd
Priority to GBGB1612095.8A priority Critical patent/GB201612095D0/en
Publication of GB201612095D0 publication Critical patent/GB201612095D0/en
Priority to PCT/GB2017/052042 priority patent/WO2018011570A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
GBGB1612095.8A 2016-07-12 2016-07-12 Pharmaceutical compounds Ceased GB201612095D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1612095.8A GB201612095D0 (en) 2016-07-12 2016-07-12 Pharmaceutical compounds
PCT/GB2017/052042 WO2018011570A1 (en) 2016-07-12 2017-07-12 Wee-1 inhibiting pyridopyrimidinone compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1612095.8A GB201612095D0 (en) 2016-07-12 2016-07-12 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB201612095D0 true GB201612095D0 (en) 2016-08-24

Family

ID=56890770

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1612095.8A Ceased GB201612095D0 (en) 2016-07-12 2016-07-12 Pharmaceutical compounds

Country Status (2)

Country Link
GB (1) GB201612095D0 (en)
WO (1) WO2018011570A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190130621A (en) 2017-03-31 2019-11-22 시애틀 지네틱스, 인크. Combination of CHK1 Inhibitors and WEE1 Inhibitors
AU2018347307A1 (en) 2017-10-09 2020-04-23 Nuvation Bio Inc. Heterocyclic compounds and uses thereof
US11299493B2 (en) 2017-10-09 2022-04-12 Nuvation Bio Inc. Heterocyclic compounds and uses thereof
WO2020192581A1 (en) 2019-03-22 2020-10-01 首药控股(北京)有限公司 Wee1 inhibitor and preparation and use thereof
WO2020210375A1 (en) 2019-04-09 2020-10-15 Nuvation Bio Inc. Heterocyclic compounds and uses thereof
EP4169919A1 (en) 2020-06-17 2023-04-26 Wigen Biomedicine Technology (Shanghai) Co., Ltd. Pyrazolo[3,4-d]pyrimidine-3-ketone derivative as wee-1 inhibitor
BR112023022236A2 (en) 2021-04-30 2024-02-06 Wigen Biomedicine Tech Shanghai Co Ltd COMPOUND OF GENERAL FORMULA (1) OR ISOMER, CRYSTALLINE FORM, PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE; PHARMACEUTICAL COMPOSITION; AND; USE OF THE COMPOUND OR ITS ISOMER, CRYSTALLINE FORM, PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE
WO2022256680A1 (en) * 2021-06-04 2022-12-08 Atrin Pharmaceuticals Pyridopyrimidine derivatives useful as wee1 kinase inhibitors
WO2023010354A1 (en) * 2021-08-04 2023-02-09 四川大学华西医院 Small molecule compound having egfr inhibitory activity, and preparation method therefor and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9718821B2 (en) * 2012-02-23 2017-08-01 Abbvie Inc. Pyridopyrimidinone inhibitors of kinases
GB201306610D0 (en) * 2013-04-11 2013-05-29 Almac Discovery Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
WO2018011570A1 (en) 2018-01-18

Similar Documents

Publication Publication Date Title
IL266017A (en) Pharmaceutical compounds
GB201612092D0 (en) Pharmaceutical compounds
IL258213A (en) Pharmaceutical compounds
GB201617758D0 (en) Pharmaceutical compounds
GB201506658D0 (en) Pharmaceutical compounds
IL258246A (en) Pharmaceutical compounds
GB201504675D0 (en) Pharmaceutical compounds
GB201506660D0 (en) Pharmaceutical compounds
ZA201900540B (en) Pharmaceutical compounds
GB201519352D0 (en) Pharmaceutical compounds
HUE052107T2 (en) Pharmaceutical compounds
GB201709652D0 (en) Pharmaceutical compounds
GB201612095D0 (en) Pharmaceutical compounds
GB201617454D0 (en) Pharmaceutical compounds
GB201704965D0 (en) Pharmaceutical compounds
GB201704714D0 (en) Pharmaceutical compounds
GB201703881D0 (en) Pharmaceutical compounds
GB201506933D0 (en) Pharmaceutical compounds
GB201502567D0 (en) Pharmaceutical compounds
GB201706806D0 (en) Pharmaceutical compounds
GB201704966D0 (en) Pharmaceutical compounds
GB201617871D0 (en) Pharmaceutical compounds
ZA201904033B (en) Pharmaceutical compounds
GB201615912D0 (en) Pharmaceutical compound
GB201615916D0 (en) Pharmaceutical compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)